Has Aubrey Hartmann, MD received payments from drug or device companies?

Yes. Drug and device makers reported $230,194 in general payments to Aubrey Hartmann, MD across 1,536 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aubrey Hartmann, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aubrey Hartmann, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aubrey Hartmann, MD

Dermatology · Cedar Park, TXNPI 1194713933

Payments from drug & device makers

$230,194in general payments, 2019–2025

Across 1,536 payments — averaging $149.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$125K
LEO Pharma Inc.$31K
Galderma Laboratories, L.p.$19K
Johnson & Johnson$12K
E.r. Squibb & Sons, L.L.C.$6K
UCB, Inc.$6K
plus $30K from 42 others

What the payments were for

Consulting fees$55,05224%
Speaking & faculty fees$121,42353%
Travel & lodging$16,6307%
Food & beverage$36,24916%
Education$8400%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	362	$125,239
LEO Pharma Inc.	76	$31,412
Galderma Laboratories, L.p.	98	$18,758
Johnson & Johnson	258	$12,370
E.r. Squibb & Sons, L.L.C.	42	$6,402
UCB, Inc.	92	$6,348
Sanofi	64	$5,176
Regeneron Healthcare Solutions, Inc.	77	$3,918
Ortho Dermatologics, A Division Of Bausch Health US, LLC	38	$3,610
Arcutis Biotherapeutics, Inc.	43	$2,940
Pfizer	59	$2,907
Dermavant Sciences, Inc.	39	$2,746
Novartis	73	$2,227
Sun Pharmaceutical Industries Inc.	43	$1,215
Lilly USA, LLC	27	$874
Amgen	25	$605
Incyte Corporation	20	$521
Janssen Scientific Affairs, LLC	4	$475
VYNE Pharmaceuticals Inc.	15	$293
Mayne Pharma Commercial LLC	13	$257
Kerecis Limited	3	$199
Journey Medical Corporation	5	$185
Boehringer Ingelheim	6	$145
Fresenius Kabi USA, LLC	5	$121
Helsinn Therapeutics (U.S.), Inc.	2	$118
Merck	2	$114
Strata Skin Sciences, Inc.	4	$113
EPI Health, LLC	6	$109
Organon	6	$101
Sanofi-aventis U.S. LLC	1	$100
Elekta, Inc.	2	$97
Almirall LLC	4	$72
Medimetriks Pharmaceuticals, Inc.	3	$47
Organogenesis Inc.	2	$47
Mallinckrodt Hospital Products Inc.	2	$45
Merz North America, Inc.	1	$39
Encore Dermatology Inc.	2	$34
Dermira, Inc.	2	$29
Mylan Institutional Inc.	1	$26
DUSA Pharmaceuticals, Inc.	1	$22
Taro Pharmaceuticals USA, Inc.	1	$20
Aclaris Therapeutics, Inc.	1	$18
Bausch Health US, LLC	1	$18
Promius Pharma LLC	1	$16
Kyowa Kirin, Inc.	1	$16
Botanix SB Inc	1	$15
LNHC, Inc	1	$15
Sebela Pharmaceuticals Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$80,266
Skyrizi$31,803
ADBRY$25,940
NEMLUVIO$17,165
ANZUPGO$10,988
Tremfya$7,787
DUPIXENT$6,523
SILIQ$2,796
ZORYVE$2,275
VTAMA$2,267
CIBINQO$2,060
COSENTYX$722
ALTRENO$355
AKLIEF$298
EPSOLAY$298
ILUMYA$250
Cimzia$247
BRYHALI$245
DUOBRII$223
TWYNEO$149

How this compares

$230,194 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$559,999

Medicare patients

1,050

Services billed

9,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	39	$162,730
Dupixent SyringeDupilumab	12	$44,726
Clobetasol Propionate	146	$7,565
Doxycycline Hyclate	302	$7,479
Ketoconazole	271	$4,583
Betamethasone Dipropionate	110	$4,305
Triamcinolone Acetonide	208	$3,302
Acitretin	13	$3,241
Minoxidil	285	$2,744
Fluorouracil	44	$2,558
Metronidazole	44	$2,558
Fluocinonide	50	$1,862
ValacyclovirValacyclovir Hcl	66	$1,602
Clindamycin Phosphate	70	$1,289
Calcipotriene	14	$1,147

Paid to pharmacies, not to this prescriber.

Other dermatology in Cedar Park

Stephen TyringWebster$14.1M
Edward LainAustin$12M
Mark LeeSan Antonio$10.9M
John BrowningSan Antonio$10.7M
Craig TellerBellaire$7.7M
Patricia LeeWebster$7.2M
Jennifer CatherDallas$4.9M
Michael MigdenHouston$3.7M
Martin MenterDallas$3.7M
Janet DuboisAustin$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →